{
  "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9",
  "docSlug": "ed8052d583ef5c8745075e02dbad124b",
  "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides",
  "authorId": "maia-biotechnology",
  "authorName": "MAIA Biotechnology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 31,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": "The slide contrasts the massive combined market of established CPIs ($42B) with the smaller market share of Libtayo ($0.5B) to frame the opportunity for partnership/growth.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/26",
  "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9",
  "deckJsonHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9.json",
  "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.55,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Checkpoint Inhibitors Market $42B combined vs $0.5B",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f973b8fd-413f-406c-a728-8525317fd98d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.55,
        "y": 0.65
      },
      "kind": "image",
      "text": "Keytruda, Opdivo, Libtayo, Tecentriq, Imfinzi logos",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e8d4dcc6-2804-4754-bea2-300b15fe8473",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.08,
        "y": 0.45
      },
      "kind": "list",
      "text": "$42B CPIs Group: 5 CPIs approved for NSCLC sold $12B; >30% of NSCLC drug sales; >40% of total CPI sales; Keytruda: $7.5B in NSCLC of $21B total",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64b53f61-906d-4f2d-9f45-efa97bacae13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.08,
        "y": 0.7
      },
      "kind": "list",
      "text": "Partnership with Regeneron (Libtayo): Profile similar to Keytruda; Libtayo is entrant #5 in CPIs; Needs superior efficacy to Keytruda; Sequential combination with THIO is key",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7c258af1-190c-465f-8b0e-07aabc98f181",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.08,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Developing agents for the top tumor types markets globally",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c150641-ce61-41a5-8b41-e23b0d64e630",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.1,
        "y": 0.27
      },
      "kind": "table",
      "text": "NSCLC (#1 WW) Mortality: 1.7M Sales: $34B | CRC (#2 WW) Mortality: 1.0M Sales: $20B",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa474f4f-0eec-488e-a3de-0e525ed26d1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "SIGNIFICANT MARKET OPPORTUNITY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c7cc5a8-ad4f-417c-88fd-ea0968202050",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "074508c6-0753-4682-af8c-b95270c33381",
      "evidence": "table/data: NSCLC (#1 WW) Mortality: 1.7M Sales: $34B | CRC (#2 WW) Mortality: 1.0M Sales: $20B",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 26,
      "from": 26,
      "beatId": "6aa71901-b154-41b0-bf7f-47c4f9470244",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The 'market_sizing' slide discusses market opportunity",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}